1
项与 nL-LMNB1-001 相关的临床试验 / Enrolling by invitation临床1/2期IIT An Open-label, Single-center, Single-participant Study of an Experimental Antisense Oligonucleotide Treatment for a Patient with LMNB1 Mutation Associated Autosomal Dominant Leukodystrophy (ADLD)
This research project entails delivery of a personalized antisense oligonucleotide (ASO) drug designed for a single participant with Autosomal Dominant Leukodystrophy (ADLD) due to LMNB1 mutation
100 项与 nL-LMNB1-001 相关的临床结果
100 项与 nL-LMNB1-001 相关的转化医学
100 项与 nL-LMNB1-001 相关的专利(医药)
100 项与 nL-LMNB1-001 相关的药物交易